Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 8, 2012 - Issue
Submit an article Journal homepage
68
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing–remitting multiple sclerosis?

Zsolt Mezei1 Department of Neurology, University of Debrecen, Debrecen, Hungary
,
Daniel Bereczki1 Department of Neurology, University of Debrecen, Debrecen, Hungary;2 Department of Neurology, Semmelweis University, Budapest, Hungary
,
Lilla Racz1 Department of Neurology, University of Debrecen, Debrecen, Hungary
,
Laszlo Csiba1 Department of Neurology, University of Debrecen, Debrecen, Hungary
&
Tünde Csepany1 Department of Neurology, University of Debrecen, Debrecen, HungaryCorrespondence[email protected]
Pages 465-473 | Published online: 23 Oct 2012

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Luca Prosperini, Marco Capobianco & Costanza Giannì. (2014) Identifying responders and nonresponders to interferon therapy in multiple sclerosis. Degenerative Neurological and Neuromuscular Disease 4, pages 75-85.
Read now

Articles from other publishers (1)

Elisabet Matas, Laura Bau, María Martínez-Iniesta, Lucía Romero-Pinel, Maria Alba Mañé-Martínez & Sergio Martínez-Yélamos. (2016) Absence of MxA induction is related to a poor clinical response to interferon beta treatment in multiple sclerosis patients. Journal of Neurology 263:4, pages 722-729.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.